Tesamorelin targets HIV-related lipodystrophy with 20% visceral fat reduction over 6 months, while sermorelin treats broader growth hormone deficiency with moderate fat loss effects Tesamorelin requires daily 2mg injections at $1,500-2,500 monthly, while sermorelin uses flexible dosing (0 } Sermorelin's Physiology Natural Stimulation: Endogenous GHRH receptor activation Preservation of natural GH pulsatility Maintenance of feedback mechanisms Support of circadian rhythms Gradual system optimization Normalized GH secretion patterns Balanced IGF-1 production Enhanced somatostatin regulation Improved hormone synchronization Sustained therapeutic response Clinical Research Findings Several studies have documented the efficacy and safety profiles of both peptides
Because metal complex stoichiometry and salt form can vary, chemical details should be confirmed against the supplier COA and analytical method
Harlia E, Rahmah KN, Nora L, Nababan JA, Hidayati YA, Marlina ET, et al
It's possible that AOD9604 may influence the fat cells and lipolytic receptors, particularly given its observed association with changes in weight and fat in murine models